226 related articles for article (PubMed ID: 28612468)
1. Decision-making processes among men with low-risk prostate cancer: A survey study.
Hoffman RM; Van Den Eeden SK; Davis KM; Lobo T; Luta G; Shan J; Aaronson D; Penson DF; Leimpeter AD; Taylor KL
Psychooncology; 2018 Jan; 27(1):325-332. PubMed ID: 28612468
[TBL] [Abstract][Full Text] [Related]
2. Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.
Taylor KL; Hoffman RM; Davis KM; Luta G; Leimpeter A; Lobo T; Kelly SP; Shan J; Aaronson D; Tomko CA; Starosta AJ; Hagerman CJ; Van Den Eeden SK
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1240-50. PubMed ID: 27257092
[TBL] [Abstract][Full Text] [Related]
3. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
[TBL] [Abstract][Full Text] [Related]
4. Does Patient Preference Measurement in Decision Aids Improve Decisional Conflict? A Randomized Trial in Men with Prostate Cancer.
Shirk JD; Crespi CM; Saucedo JD; Lambrechts S; Dahan E; Kaplan R; Saigal C
Patient; 2017 Dec; 10(6):785-798. PubMed ID: 28623628
[TBL] [Abstract][Full Text] [Related]
5. How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancer.
Lamers RE; Cuypers M; de Vries M; van de Poll-Franse LV; Ruud Bosch JL; Kil PJ
Urol Oncol; 2017 Feb; 35(2):37.e9-37.e17. PubMed ID: 28341494
[TBL] [Abstract][Full Text] [Related]
6. How older patients' treatment preferences are influenced by disclosures about therapeutic uncertainty: surgery versus expectant management for localized prostate cancer.
Mazur DJ; Merz JF
J Am Geriatr Soc; 1996 Aug; 44(8):934-7. PubMed ID: 8708303
[TBL] [Abstract][Full Text] [Related]
7. Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study.
Bergengren O; Garmo H; Bratt O; Holmberg L; Johansson E; Bill-Axelson A
Eur Urol Oncol; 2018 May; 1(1):37-45. PubMed ID: 31100227
[TBL] [Abstract][Full Text] [Related]
8. Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study.
Gore JL; du Plessis M; Santiago-Jiménez M; Yousefi K; Thompson DJS; Karsh L; Lane BR; Franks M; Chen DYT; Bandyk M; Bianco FJ; Brown G; Clark W; Kibel AS; Kim HL; Lowrance W; Manoharan M; Maroni P; Perrapato S; Sieber P; Trabulsi EJ; Waterhouse R; Davicioni E; Lotan Y; Lin DW
Cancer; 2017 Aug; 123(15):2850-2859. PubMed ID: 28422278
[TBL] [Abstract][Full Text] [Related]
9. Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
Mallapareddi A; Ruterbusch J; Reamer E; Eggly S; Xu J
Fam Pract; 2017 Feb; 34(1):90-97. PubMed ID: 28034917
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer survivors with a passive role preference in treatment decision-making are less satisfied with information received: Results from the PROFILES registry.
Cuypers M; Lamers RED; de Vries M; Husson O; Kil PJM; van de Poll-Franse LV
Urol Oncol; 2016 Nov; 34(11):482.e11-482.e18. PubMed ID: 27432432
[TBL] [Abstract][Full Text] [Related]
11. Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of Care.
Johnson DC; Mueller DE; Deal AM; Dunn MW; Smith AB; Woods ME; Wallen EM; Pruthi RS; Nielsen ME
J Urol; 2016 Dec; 196(6):1640-1644. PubMed ID: 27346032
[TBL] [Abstract][Full Text] [Related]
12. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
Davison BJ; Goldenberg SL
BJU Int; 2011 Dec; 108(11):1787-93. PubMed ID: 21507187
[TBL] [Abstract][Full Text] [Related]
13. Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer.
Hoffman RM; Lobo T; Van Den Eeden SK; Davis KM; Luta G; Leimpeter AD; Aaronson D; Penson DF; Taylor K
Med Decis Making; 2019 Nov; 39(8):962-974. PubMed ID: 31631745
[No Abstract] [Full Text] [Related]
14. Prostatectomy versus radiotherapy for early-stage prostate cancer (PREPaRE) study: protocol for a mixed-methods study of treatment decision-making in men with localised prostate cancer.
Smith AB; Mancuso P; Sidhom M; Wong K; Berry M; Rincones O; Forstner D; Bokey L; Girgis A
BMJ Open; 2017 Nov; 7(11):e018403. PubMed ID: 29102996
[TBL] [Abstract][Full Text] [Related]
15. 'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option.
O'Callaghan C; Dryden T; Hyatt A; Brooker J; Burney S; Wootten AC; White A; Frydenberg M; Murphy D; Williams S; Schofield P
Psychooncology; 2014 Dec; 23(12):1391-8. PubMed ID: 24830805
[TBL] [Abstract][Full Text] [Related]
16. Patient perspective on watchful waiting/active surveillance for localized prostate cancer.
Xu J; Neale AV; Dailey RK; Eggly S; Schwartz KL
J Am Board Fam Med; 2012; 25(6):763-70. PubMed ID: 23136314
[TBL] [Abstract][Full Text] [Related]
17. What Is a "Good" Treatment Decision? Decisional Control, Knowledge, Treatment Decision Making, and Quality of Life in Men with Clinically Localized Prostate Cancer.
Orom H; Biddle C; Underwood W; Nelson CJ; Homish DL
Med Decis Making; 2016 Aug; 36(6):714-25. PubMed ID: 26957566
[TBL] [Abstract][Full Text] [Related]
18. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study.
Myers RE; Leader AE; Censits JH; Trabulsi EJ; Keith SW; Petrich AM; Quinn AM; Den RB; Hurwitz MD; Lallas CD; Hegarty SE; Dicker AP; Zeigler-Johnson CM; Giri VN; Ayaz H; Gomella LG
J Cancer Educ; 2018 Feb; 33(1):180-185. PubMed ID: 27418065
[TBL] [Abstract][Full Text] [Related]
19. Choosing active surveillance versus curative treatment in a population-based survey of men with low-risk prostate cancer.
Xu J; Janisse J; Goodman M
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696653
[TBL] [Abstract][Full Text] [Related]
20. Patient Knowledge and Qualities of Treatment Decisions for Localized Prostate Cancer.
Daum LM; Reamer EN; Ruterbusch JJ; Liu J; Holmes-Rovner M; Xu J
J Am Board Fam Med; 2017; 30(3):288-297. PubMed ID: 28484061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]